Vistara | Natera

Vistara facilitates early diagnosis for skeletal, cardiac, and neurological disorders

Vistara facilitates early diagnosis for skeletal, cardiac, and neurological disorders

Vistara facilitates early diagnosis for skeletal, cardiac, and neurological disorders

Vistara facilitates early diagnosis for skeletal, cardiac, and neurological disorders

Conditions screened by Vistara have a combined incidence of 1 in 600 – higher than that of Down syndrome

Vistara screens cell-free DNA (cfDNA) for serious genetic conditions that affect quality of life and may benefit from medical and/or surgical intervention

Screened conditions include:

  • Noonan syndrome
  • Achondroplasia
  • Osteogenesis imperfecta
  • Rett syndrome
  • And 21 other single-gene disorders across 30 genes

SEE ALL CONDITIONS

Vistara screens cell-free DNA (cfDNA) for serious genetic conditions that affect quality of life and may benefit from medical and/or surgical intervention

Screened conditions include:

  • Noonan syndrome
  • Achondroplasia
  • Osteogenesis imperfecta
  • Rett syndrome
  • And 21 other single-gene disorders across 30 genes

SEE ALL CONDITIONS

Vistara screens cell-free DNA (cfDNA) for serious genetic conditions that affect quality of life and may benefit from medical and/or surgical intervention

Screened conditions include:

  • Noonan syndrome
  • Achondroplasia
  • Osteogenesis imperfecta
  • Rett syndrome
  • And 21 other single-gene disorders across 30 genes

SEE ALL CONDITIONS

Vistara screens cell-free DNA (cfDNA) for serious genetic conditions that affect quality of life and may benefit from medical and/or surgical intervention

Screened conditions include:

  • Noonan syndrome
  • Achondroplasia
  • Osteogenesis imperfecta
  • Rett syndrome
  • And 21 other single-gene disorders across 30 genes

SEE ALL CONDITIONS

Vistara has a combined analytical sensitivity and specificity of >99% in validation studies and no known false positives in commercial experience.

Vistara has a combined analytical sensitivity and specificity of >99% in validation studies and no known false positives in commercial experience.

Vistara has a combined analytical sensitivity and specificity of >99% in validation studies and no known false positives in commercial experience.

Vistara has a combined analytical sensitivity and specificity of >99% in validation studies and no known false positives in commercial experience.

Vistara identifies risk for single-gene disorders that may have otherwise gone undetected prenatally

  • Ultrasound findings are not a reliable indicator
  • Conditions are not detected with standard karyotype or microarray analysis
  • Family history is typically not a good indicator of risk (often de novo)
  • Early identification of these conditions is clinically actionable

Prenatal screening with Vistara can lead to improved delivery management and targeted neonatal care

Disorder Clinical actions
Noonan syndrome
  • Fetal echocardiogram
  • Labor and delivery management
  • Early assessment for learning differences
Achondroplasia
  • Labor and delivery management
  • Monitor for spinal stenosis
  • Early sleep studies to reduce risk of SIDS
Osteogenesis imperfecta
  • Labor and delivery management to avoid fractures
  • Neonatal care
  • Early recognition and treatment of fractures

Prenatal screening with Vistara can lead to improved delivery management and targeted neonatal care

Disorder Clinical actions
Noonan syndrome
  • Fetal echocardiogram
  • Labor and delivery management
  • Early assessment for learning differences
Achondroplasia
  • Labor and delivery management
  • Monitor for spinal stenosis
  • Early sleep studies to reduce risk of SIDS
Osteogenesis imperfecta
  • Labor and delivery management to avoid fractures
  • Neonatal care
  • Early recognition and treatment of fractures

Prenatal screening with Vistara can lead to improved delivery management and targeted neonatal care

Disorder Clinical actions
Noonan syndrome
  • Fetal echocardiogram
  • Labor and delivery management
  • Early assessment for learning differences
Achondroplasia
  • Labor and delivery management
  • Monitor for spinal stenosis
  • Early sleep studies to reduce risk of SIDS
Osteogenesis imperfecta
  • Labor and delivery management to avoid fractures
  • Neonatal care
  • Early recognition and treatment of fractures

Prenatal screening with Vistara can lead to improved delivery management and targeted neonatal care

Disorder Clinical actions
Noonan syndrome
  • Fetal echocardiogram
  • Labor and delivery management
  • Early assessment for learning differences
Achondroplasia
  • Labor and delivery management
  • Monitor for spinal stenosis
  • Early sleep studies to reduce risk of SIDS
Osteogenesis imperfecta
  • Labor and delivery management to avoid fractures
  • Neonatal care
  • Early recognition and treatment of fractures

Consider Vistara for the following indications

Back to Top